Index of /wp-content/uploads/2021/07/
| Name | Last Modified | Size |
|---|---|---|
 Parent Directory | ||
 Cenobamate-21025-Technical-Summary-Document.pdf | 2023-03-09 11:31 | 611k |
| Cenobamate-Ontozry-21025-Plain-English-Summary.pdf | 2023-03-09 11:31 | 319k |
| Empagliflozin-plain-English-Summary.docx.pdf | 2023-03-09 11:31 | 340k |
| Empagliflozin-website-summary.docx.pdf | 2023-03-09 11:31 | 475k |
| Ruxolitinib-20008-Plain-Language-Summary.pdf | 2023-03-09 11:31 | 201k |
| Ruxolitinib-20008-Website-Summary.pdf | 2023-03-09 11:31 | 327k |
| Ruxolitinib-August-2016-Summary.pdf | 2023-03-09 11:31 | 334k |
| Sativex-Plain-English-Summary-NCPE-July21.pdf | 2023-03-09 11:31 | 205k |
| Sativex-summary-2014.pdf | 2023-03-09 11:31 | 145k |
| Sativex-Tech-Summary-Final-20.07.2021.pdf | 2023-03-09 11:31 | 246k |
| SativexSummary.pdf | 2023-03-09 11:31 | 246k |
| Vericiguat-plain-English-Summary.-HTA-ID-21027.pdf | 2023-03-09 11:31 | 339k |
| Vericiguat-Technical-Summary.-HTA-ID-21027.docx.pdf | 2023-03-09 11:31 | 487k |